MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma
BACKGROUND: Gliomas account for 75% of all primary malignant brain tumors in adults and result in high mortality. Accumulated evidence has declared the minichromosome maintenance protein complex (MCM) gene family plays a critical role in modulating the cell cycle and DNA replication stress. However,...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713251/ https://www.ncbi.nlm.nih.gov/pubmed/36465369 http://dx.doi.org/10.3389/fonc.2022.1004324 |